| Product NDC: | 0942-9005 |
| Proprietary Name: | ACD-A |
| Non Proprietary Name: | Antiocoagulant Citrate Dextrose Solution, Formula A |
| Active Ingredient(s): | 730; 2.45; 2.2 mg/100mL; g/100mL; g/100mL & nbsp; Antiocoagulant Citrate Dextrose Solution, Formula A |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0942-9005 |
| Labeler Name: | Fenwal Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BN160918 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20121024 |
| Package NDC: | 0942-9005-01 |
| Package Description: | 1000 mL in 1 BAG (0942-9005-01) |
| NDC Code | 0942-9005-01 |
| Proprietary Name | ACD-A |
| Package Description | 1000 mL in 1 BAG (0942-9005-01) |
| Product NDC | 0942-9005 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Antiocoagulant Citrate Dextrose Solution, Formula A |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20121024 |
| Marketing Category Name | NDA |
| Labeler Name | Fenwal Inc. |
| Substance Name | ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM CITRATE |
| Strength Number | 730; 2.45; 2.2 |
| Strength Unit | mg/100mL; g/100mL; g/100mL |
| Pharmaceutical Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |